AngioSoma, Inc. (OTC: SOAN) Announces Launch of www.soma-ceuticals.com Website

HOUSTON--(BUSINESS WIRE)-- We are pleased to announce we have initiated our new website, http://www.soma-ceuticals.com to market our SomaceuticalsTM line of health supplements. Our innovative supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.
 
Nutraceuticals lead off with StemStrengthTM, an all-natural stimulant for accelerated muscle and tissue development and RockOnTM, a potent libido complex tonic for male and female usage, containing popular ingredients for sexual health.
 
Cosmeceuticals include three products:
 
Rapid Wrinkle Reducer: a skin-smoothing serum gentle enough for everyday use. Instant results from plant extracts help reduce the appearance of fine lines and wrinkles and help to combat the appearance of aging skin.
 
Powerful Peptide Eye Serum: helps to reduce the appearance of eye bags, dark circles, and puffy eyes by relieving the accumulation of fluids and increasing the firmness around your eyes.
 
Collagen Anti-Aging Crème: nourishes and protects skin while encouraging skin cell renewal. It supports elastin and collagen production, which promotes skin moisture, elasticity, and thickness. It also has a healing effect on troubled or damaged skin areas.
 
Our lead pharmaceutical candidate is, patent pending, Omnicath-2TM that will cut, scrap, grind, balloon vessel remodel, irrigate, and aspirate all types of vessel blockages from all sorts of plaque – all done under direct vision, optical coherence tomography, or infrared visualization. We have completed product testing of an earlier version of our Omnicath-2.
 
Alex Blankenship, CEO, expressed her appreciation for the valuable contribution of AllianceTek for developing the marketing strategy as well as the design and creation of the marketing website.
 
ABOUT ANGIOSOMA, INC.

AngioSoma, Inc. (http://www.angiosoma.com), a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we have launched a line of supplements under our SomaceuticalsTM common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.

Contacts

AngioSoma, Inc.
Alex Blankenship
investors@AngioSoma.com

 
 

Source: AngioSoma, Inc.

Back to news